Active Substance & Generic Molecule Directory
Oryza Sativa in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Oryza Sativa registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
9
Registered Brands
Availability in Malaysia:9 Traditional (MAL-T)
Showing 9 of 9 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL19076120TC | ''TIMING'' NEW FEI ER BA JHEN GAO EXTRACT GRANULES | 1607 mg 3.6 g | Traditional Herbal (MAL-T) | Timing Herbs Sdn Bhd | Compare → |
| MAL12125031T | CHANG-SZE-LONG XIAO'ER QIXINGCHA TANGJIANG | 3.662ml 20ml | Traditional Herbal (MAL-T) | NANG HIN MEDICAL SDN. BHD. | Compare → |
| MAL26056057T | Edmark Shake Off Capsule | 170 mg 400 mg | Traditional Herbal (MAL-T) | EDMARK INDUSTRIES SDN BHD | Compare → |
| MAL19016048TC | ener369 Oryza Sativa Bran Oil & Mangostin Extract in Vegetable Softgel | 445.0000 mg 830.0000 mg | Traditional Herbal (MAL-T) | MOC MARKETING SDN BHD | Compare → |
| MAL21106111TC | Pharmanex ageLOC RESET Softgel | 300 mg 1401.81 mg | Traditional Herbal (MAL-T) | NU SKIN (MALAYSIA) SDN. BHD. | Compare → |
| MAL23106122TC | Seiketsu Blacsemenuro III Vegetable Capsule | 200 mg 500 mg | Traditional Herbal (MAL-T) | Seiketsu Enterprise Sdn Bhd | Compare → |
| MAL17045004TC | Seiketsu Blacsemenuro Vegetable Capsule | 250mg 500mg | Traditional Herbal (MAL-T) | Seiketsu Enterprise Sdn Bhd | Compare → |
| MAL13095069T | SHAFLI SOFTGEL | 100.80mg 560.00mg | Traditional Herbal (MAL-T) | SHAFLI LAGENDA SDN. BHD. | Compare → |
| MAL14015104T | Xin Shieh Bor Sann Extract Pulveres'TI' | 0.11gm 1.0gm | Traditional Herbal (MAL-T) | TIAN I BIOTECH INTERNATIONAL SDN BHD | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.